|
Volumn 63, Issue 22, 2006, Pages 2168-
|
Vorinostat approved for rare lymphoma.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
HISTONE DEACETYLASE;
HYDROXAMIC ACID;
VORINOSTAT;
ARTICLE;
CUTANEOUS T CELL LYMPHOMA;
DRUG ANTAGONISM;
DRUG APPROVAL;
DRUG LABELING;
ENZYMOLOGY;
HUMAN;
METABOLISM;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
DRUG LABELING;
ENZYME INHIBITORS;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
LYMPHOMA, T-CELL, CUTANEOUS;
MLCS;
MLOWN;
|
EID: 33947306060
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news060020 Document Type: Article |
Times cited : (14)
|
References (0)
|